general
Business News | Why Early Referral Is Becoming Central to CAR-T Outcomes in India
Get latest articles and stories on Business at LatestLY. New Delhi [India], September 21: India’s first indigenous CAR-T therapy, NexCAR 19 has moved an advanced form of cancer treatment from the realm of possibility into real-world clinical practice. Physicians treating relapsed and refractory blood cancers now face a new set of decisions — which patients to refer, when, and how safely the therapy can be delivered.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
निर्वाचन आयोग ने पिछले फैसलों की समीक्षा की: एसआईआर में सुनवाई और फॉर्म के नियम बदले; क्यों?
Amar Ujala
‘Conspiracy’ against Punjab, university & Hindu-Sikh unity: LPU Chancellor Ashok Mittal
The Indian Express
Soon after SIR, Odisha’s Chief Electoral Officer applies VRS
The Hindu
Avoid ‘dangerous path’ of travelling to Russia to join army: MEA
The Hindu
‘A hero’: Trump on Indian pilot Smit Machchhar after mid-air cockpit attack
The Indian Express